NCT01871571 Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer Status UNKNOWN Phase PHASE2
NCT01847326 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT01835041 CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01814501 Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab Status COMPLETED Phase PHASE2
NCT01779050 Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Status TERMINATED Phase PHASE2
NCT01747551 FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT01740648 Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer Status COMPLETED Phase PHASE1
NCT01715233 Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. Status COMPLETED Phase PHASE2
NCT01711541 Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01666730 Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01658943 Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT01652196 Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01643499 Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies Status COMPLETED Phase PHASE1
NCT01567618 Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT01566435 Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer Status COMPLETED Phase PHASE2
NCT01561014 Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Status COMPLETED Phase PHASE1
NCT01534637 Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer Status COMPLETED Phase PHASE2